Total Payments
$8,930
2024 Payments
$1,368
Companies
38
Transactions
521
Medicare Patients
1,364
Medicare Billing
$163,367
Payment Breakdown by Category
Food & Beverage$8,930 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,930 | 519 | 100.0% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
General
$8,930
519 transactions
Ownership
$0
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,102 | 123 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,171 | 80 | $0 (2024) |
| Janssen Biotech, Inc. | $691.98 | 32 | $0 (2024) |
| PFIZER INC. | $654.30 | 34 | $0 (2024) |
| Celgene Corporation | $536.02 | 56 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $496.38 | 30 | $0 (2024) |
| Allergan, Inc. | $443.71 | 21 | $0 (2020) |
| Gilead Sciences, Inc. | $435.54 | 26 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $268.73 | 12 | $0 (2024) |
| QOL Medical, LLC | $221.90 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,368 | 80 | ABBVIE INC. ($329.85) |
| 2023 | $1,422 | 83 | AbbVie Inc. ($391.34) |
| 2022 | $1,424 | 74 | ABBVIE INC. ($443.57) |
| 2021 | $813.92 | 58 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($400.22) |
| 2020 | $394.87 | 26 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($151.17) |
| 2019 | $1,017 | 67 | AbbVie, Inc. ($223.05) |
| 2018 | $1,134 | 64 | AbbVie, Inc. ($235.82) |
| 2017 | $1,356 | 69 | AbbVie, Inc. ($321.50) |
All Payment Transactions
521 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.19 | General |
| 11/20/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Immunology | ||||||
| 10/29/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/11/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.72 | General |
| 09/30/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/26/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/24/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $146.68 | General |
| Category: LIVER DISEASE | ||||||
| 09/24/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.94 | General |
| Category: Neuroscience | ||||||
| 09/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.71 | General |
| Category: Neuroscience | ||||||
| 09/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.22 | General |
| Category: Neuroscience | ||||||
| 08/28/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Immunology | ||||||
| 08/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/09/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 306 | 333 | $217,005 | $37,903 |
| 2022 | 10 | 325 | 367 | $197,551 | $37,482 |
| 2021 | 10 | 380 | 442 | $293,703 | $47,539 |
| 2020 | 11 | 353 | 405 | $264,950 | $40,444 |
Total Patients
1,364
Total Services
1,547
Medicare Billing
$163,367
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 51 | 51 | $73,884 | $10,595 | 14.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 65 | $16,445 | $5,910 | 35.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 43 | 43 | $50,611 | $5,599 | 11.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 42 | 43 | $35,239 | $3,781 | 10.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 54 | $10,098 | $3,772 | 37.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $10,049 | $3,601 | 35.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 13 | 13 | $13,514 | $2,471 | 18.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $4,703 | $1,127 | 24.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 16 | $2,464 | $1,046 | 42.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 27 | 27 | $43,634 | $5,893 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 59 | 85 | $13,780 | $5,600 | 40.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $10,877 | $4,074 | 37.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 36 | 38 | $44,751 | $4,048 | 9.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 43 | $10,350 | $4,026 | 38.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 28 | 28 | $40,147 | $3,707 | 9.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 56 | $6,791 | $3,398 | 50.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 26 | $5,858 | $2,993 | 51.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 13 | 13 | $17,718 | $2,473 | 14.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $3,645 | $1,271 | 34.9% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 39 | 39 | $68,500 | $8,548 | 12.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 80 | 113 | $15,820 | $7,935 | 50.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 52 | 60 | $90,000 | $5,678 | 6.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 38 | 38 | $11,020 | $4,837 | 43.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 41 | $9,430 | $4,320 | 45.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 32 | 32 | $51,200 | $4,201 | 8.2% |
About Dr. Gena Cobrin, MD
Dr. Gena Cobrin, MD is a Specialist healthcare provider based in Fairfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205828126.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gena Cobrin, MD has received a total of $8,930 in payments from pharmaceutical and medical device companies, with $1,368 received in 2024. These payments were reported across 521 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($8,930).
As a Medicare-enrolled provider, Cobrin has provided services to 1,364 Medicare beneficiaries, totaling 1,547 services with total Medicare billing of $163,367. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Fairfield, CT
- Active Since 08/17/2005
- Last Updated 10/30/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1205828126
Products in Payments
- XIFAXAN (Drug) $975.41
- LINZESS (Drug) $609.28
- XELJANZ (Drug) $592.24
- ZEPOSIA (Drug) $519.78
- RINVOQ (Biological) $439.26
- Humira (Biological) $435.26
- SKYRIZI (Biological) $382.03
- Entyvio (Biological) $330.57
- ENTYVIO (Biological) $248.45
- STELARA (Biological) $239.74
- REMICADE (Biological) $238.50
- TREMFYA (Drug) $213.74
- Creon (Drug) $198.67
- OCALIVA (Drug) $190.46
- Sucraid (Drug) $189.26
- DUPIXENT (Biological) $175.51
- VIBERZI (Drug) $156.06
- REZDIFFRA (Drug) $146.68
- HUMIRA (Biological) $123.32
- UCERIS (Drug) $118.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Fairfield
Dr. Eddy Castillo
Specialist — Payments: $40,030
Specialist $40,030
Dr. Julie Spivack, Md, MD
Specialist — Payments: $13,443
Specialist $13,443
Dr. Strick Woods
Specialist — Payments: $11,734
Specialist $11,734
Dr. Emil Blanco, Md, MD
Specialist — Payments: $11,406
Specialist $11,406
Dr. Edward Pinto, Md, MD
Specialist — Payments: $9,438
Specialist $9,438
Dr. Kenneth Mauer, Md, MD
Specialist — Payments: $6,373
Specialist $6,373